ARTICLE | Company News
Mitsubishi, Biogen deal
February 3, 2017 8:34 PM UTC
Mitsubishi and Biogen terminated a 2015 deal granting Biogen exclusive rights to develop and commercialize amiselimod (MT-1303) worldwide, excluding Asian territories. The small molecule sphingosine 1...
BCIQ Target Profiles